Steven R. Gullans Ph.D., Director at Gemphire Therapeutics Inc. (GEMP), bought 105,596 shares at $9.47 ($1000K) on 2017-03-10, disclosed to the SEC on 2017-03-14.
Open-market purchase of $1000k GEMP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.47 | 52,798 | $500K | 50.0% |
| 2 | $9.47 | 52,798 | $500K | 50.0% |
| Total | $9.47 avg | 105,596 | $1000K | 100% |
| Filing → |
| GEMP | BUY | 2016-08-12 | $5.0M | — | Filing → |
| TTPH | BUY | 2014-05-21 | $231K | — | Filing → |
| TTPH | BUY | 2013-03-27 | $3.5M | — | Filing → |